NASDAQ
Insight Molecular Diagnostics Inc. (IMDX) reported revenue of $4.05M and net income of $-50,222,000 for FY 2025, with a net profit margin of -1238.5%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.